Entrada Therapeutics (TRDA) Shares Issued (2020 - 2026)

Entrada Therapeutics' Shares Issued history runs 7 years deep, the most recent figure standing at $100000.0 for Q1 2026.

• In Q1 2026, Shares Issued fell 71.43% year-over-year to $100000.0; the TTM figure through Mar 2026 stood at $175000.0 (down 94.02% YoY), while the FY2025 annual figure was $425000.0, down 84.72% from the prior year.
• Shares Issued was $100000.0 for Q1 2026 at Entrada Therapeutics, down from $108000.0 in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $99.8 million in Q2 2024 to a low of -$98.3 million in Q3 2024.
• Historically, Shares Issued has averaged $288142.9 across 5 years, with a median of $231500.0 in 2023.
• Biggest YoY gain for Shares Issued was 38730.35% in 2024; the steepest drop was 26814.4% in 2024.
• A 5-year view of Shares Issued shows it stood at $284000.0 in 2022, then sank by 209.51% to -$311000.0 in 2023, then jumped by 450.8% to $1.1 million in 2024, then sank by 90.1% to $108000.0 in 2025, then fell by 7.41% to $100000.0 in 2026.
• The last three Shares Issued figures came in at $100000.0 (Q1 2026), $108000.0 (Q4 2025), and $317000.0 (Q3 2025), per Business Quant data.